• Loading stock data…

Aarvik Therapeutics and ArriVent Biopharma Announce Research Collaboration to Advance Novel Oncology Drug Candidate Using Aarvik’s Proprietary Modular Antibody Platform

[#item_full_content]

Print Friendly, PDF & Email
Spread the word